Recommended Immunization Schedule for Persons Aged 0 Through 6 Years—United States • 2010

For those who fall behind or start late, see the catch-up schedule
1 2 4 6 12 15 18 19–23 2–3 4–6
Vaccine ▼ Age ► Birth month months months months months months months months years years
Hepatitis B1 HepB HepB HepB

Rotavirus2 RV RV RV 2 Range of
recommended
see
Diphtheria, Tetanus, Pertussis3 DTaP DTaP DTaP footnote 3 DTaP DTaP ages for all
children except
Haemophilus influenzae type b4 Hib Hib Hib4 Hib certain high-risk
groups
Pneumococcal5 PCV PCV PCV PCV PPSV

Inactivated Poliovirus6 IPV IPV IPV IPV

Range of
Influenza7 Influenza (Yearly) recommended
ages for certain
Measles, Mumps, Rubella8 MMR see footnote 8 MMR high-risk groups

Varicella9 Varicella see footnote 9 Varicella

Hepatitis A10 HepA (2 doses) HepA Series

Meningococcal11 MCV

This schedule includes recommendations in effect as of December 15, 2009. Any dose events. Providers should consult the relevant Advisory Committee on Immunization
not administered at the recommended age should be administered at a subsequent Practices statement for detailed recommendations: http://www.cdc.gov/vaccines/pubs/
visit, when indicated and feasible. The use of a combination vaccine generally is acip-list.htm. Clinically significant adverse events that follow immunization should be
preferred over separate injections of its equivalent component vaccines. Considerations reported to the Vaccine Adverse Event Reporting System (VAERS) at http://www.
should include provider assessment, patient preference, and the potential for adverse vaers.hhs.gov or by telephone, 800-822-7967.

1. Hepatitis B vaccine (HepB). (Minimum age: birth) 6. Inactivated poliovirus vaccine (IPV) (Minimum age: 6 weeks)
At birth: • The final dose in the series should be administered on or after the fourth birthday
• Administer monovalent HepB to all newborns before hospital discharge. and at least 6 months following the previous dose.
• If mother is hepatitis B surface antigen (HBsAg)-positive, administer HepB and • If 4 doses are administered prior to age 4 years a fifth dose should be administered
0.5 mL of hepatitis B immune globulin (HBIG) within 12 hours of birth. at age 4 through 6 years. See MMWR 2009;58(30):829–30.
• If mother’s HBsAg status is unknown, administer HepB within 12 hours of birth. 7. Influenza vaccine (seasonal). (Minimum age: 6 months for trivalent inactivated
Determine mother’s HBsAg status as soon as possible and, if HBsAg-positive, influenza vaccine [TIV]; 2 years for live, attenuated influenza vaccine [LAIV])
administer HBIG (no later than age 1 week). • Administer annually to children aged 6 months through 18 years.
After the birth dose: • For healthy children aged 2 through 6 years (i.e., those who do not have underly-
• The HepB series should be completed with either monovalent HepB or a combina- ing medical conditions that predispose them to influenza complications), either
tion vaccine containing HepB. The second dose should be administered at age LAIV or TIV may be used, except LAIV should not be given to children aged
1 or 2 months. Monovalent HepB vaccine should be used for doses administered 2 through 4 years who have had wheezing in the past 12 months.
before age 6 weeks. The final dose should be administered no earlier than age • Children receiving TIV should receive 0.25 mL if aged 6 through 35 months or
24 weeks. 0.5 mL if aged 3 years or older.
• Infants born to HBsAg-positive mothers should be tested for HBsAg and antibody • Administer 2 doses (separated by at least 4 weeks) to children aged younger than
to HBsAg 1 to 2 months after completion of at least 3 doses of the HepB series, 9 years who are receiving influenza vaccine for the first time or who were vaccinated
at age 9 through 18 months (generally at the next well-child visit). for the first time during the previous influenza season but only received 1 dose.
• Administration of 4 doses of HepB to infants is permissible when a combination • For recommendations for use of influenza A (H1N1) 2009 monovalent vaccine
vaccine containing HepB is administered after the birth dose. The fourth dose see MMWR 2009;58(No. RR-10).
should be administered no earlier than age 24 weeks. 8. Measles, mumps, and rubella vaccine (MMR). (Minimum age: 12 months)
2. Rotavirus vaccine (RV). (Minimum age: 6 weeks) • Administer the second dose routinely at age 4 through 6 years. However, the
• Administer the first dose at age 6 through 14 weeks (maximum age: 14 weeks second dose may be administered before age 4, provided at least 28 days have
6 days). Vaccination should not be initiated for infants aged 15 weeks 0 days elapsed since the first dose.
or older. 9. Varicella vaccine. (Minimum age: 12 months)
• The maximum age for the final dose in the series is 8 months 0 days • Administer the second dose routinely at age 4 through 6 years. However, the
• If Rotarix is administered at ages 2 and 4 months, a dose at 6 months is not second dose may be administered before age 4, provided at least 3 months have
indicated. elapsed since the first dose.
3. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP). • For children aged 12 months through 12 years the minimum interval between
(Minimum age: 6 weeks) doses is 3 months. However, if the second dose was administered at least
• The fourth dose may be administered as early as age 12 months, provided at 28 days after the first dose, it can be accepted as valid.
least 6 months have elapsed since the third dose. 10. Hepatitis A vaccine (HepA). (Minimum age: 12 months)
• Administer the final dose in the series at age 4 through 6 years. • Administer to all children aged 1 year (i.e., aged 12 through 23 months). Administer
4. Haemophilus influenzae type b conjugate vaccine (Hib). 2 doses at least 6 months apart.
(Minimum age: 6 weeks) • Children not fully vaccinated by age 2 years can be vaccinated at subsequent
• If PRP-OMP (PedvaxHIB or Comvax [HepB-Hib]) is administered at ages 2 and visits
4 months, a dose at age 6 months is not indicated. • HepA also is recommended for older children who live in areas where vaccina-
• TriHiBit (DTaP/Hib) and Hiberix (PRP-T) should not be used for doses at ages tion programs target older children, who are at increased risk for infection, or for
2, 4, or 6 months for the primary series but can be used as the final dose in whom immunity against hepatitis A is desired.
children aged 12 months through 4 years. See MMWR 1997;46(No. RR-8). 11. Meningococcal vaccine. (Minimum age: 2 years for meningococcal conjugate
5. Pneumococcal vaccine. (Minimum age: 6 weeks for pneumococcal conjugate vaccine [MCV4] and for meningococcal polysaccharide vaccine [MPSV4])
vaccine [PCV]; 2 years for pneumococcal polysaccharide vaccine [PPSV]) • Administer MCV4 to children aged 2 through 10 years with persistent comple-
• PCV is recommended for all children aged younger than 5 years. Administer ment component deficiency, anatomic or functional asplenia, and certain other
1 dose of PCV to all healthy children aged 24 through 59 months who are not conditions placing tham at high risk.
completely vaccinated for their age. • Administer MCV4 to children previously vaccinated with MCV4 or MPSV4 after
• Administer PPSV 2 or more months after last dose of PCV to children aged 2 years 3 years if first dose administered at age 2 through 6 years. See MMWR 2009;​
or older with certain underlying medical conditions, including a cochlear implant. 58:1042–3.

The Recommended Immunization Schedules for Persons Aged 0 through 18 Years are approved by the Advisory Committee on Immunization Practices
(http://www.cdc.gov/vaccines/recs/acip), the American Academy of Pediatrics (http://www.aap.org), and the American Academy of Family Physicians (http://www.aafp.org).
Department of Health and Human Services • Centers for Disease Control and Prevention